Key Details
Price
$0.73Annual ROE
253.53%Beta
1.06Events Calendar
Next earnings date:
Mar 13, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
Mar 5, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Nov 14, 24 Canaccord Genuity
BuyNov 13, 24 Chardan Capital
BuyOct 24, 24 JP Morgan
UnderweightSep 13, 24 Canaccord Genuity
BuyAug 14, 24 Chardan Capital
BuyAug 14, 24 Canaccord Genuity
BuyJun 7, 24 Oppenheimer
PerformJun 7, 24 Canaccord Genuity
BuyMay 9, 24 Oppenheimer
OutperformMay 8, 24 Chardan Capital
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Seres Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Seres Therapeutics?
- Does Seres Therapeutics pay dividends?
- What sector is Seres Therapeutics in?
- What industry is Seres Therapeutics in?
- What country is Seres Therapeutics based in?
- When did Seres Therapeutics go public?
- Is Seres Therapeutics in the S&P 500?
- Is Seres Therapeutics in the NASDAQ 100?
- Is Seres Therapeutics in the Dow Jones?
- When was Seres Therapeutics's last earnings report?
- When does Seres Therapeutics report earnings?
- Should I buy Seres Therapeutics stock now?
What is the ticker symbol for Seres Therapeutics?
The ticker symbol for Seres Therapeutics is NASDAQ:MCRB
Does Seres Therapeutics pay dividends?
No, Seres Therapeutics does not pay dividends
What sector is Seres Therapeutics in?
Seres Therapeutics is in the Healthcare sector
What industry is Seres Therapeutics in?
Seres Therapeutics is in the Biotechnology industry
What country is Seres Therapeutics based in?
Seres Therapeutics is headquartered in United States
When did Seres Therapeutics go public?
Seres Therapeutics's initial public offering (IPO) was on June 26, 2015
Is Seres Therapeutics in the S&P 500?
No, Seres Therapeutics is not included in the S&P 500 index
Is Seres Therapeutics in the NASDAQ 100?
No, Seres Therapeutics is not included in the NASDAQ 100 index
Is Seres Therapeutics in the Dow Jones?
No, Seres Therapeutics is not included in the Dow Jones index
When was Seres Therapeutics's last earnings report?
Seres Therapeutics's most recent earnings report was on Nov 13, 2024
When does Seres Therapeutics report earnings?
The next expected earnings date for Seres Therapeutics is Mar 13, 2025
Should I buy Seres Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions